Loading company…
MDBiolab develops pharmaceutical treatments for kidney cancer from its base in Seoul, South Korea.
Founded in 2017 and based in Seoul, South Korea, the company develops pharmaceutical treatments for kidney cancer. Its listed stage is Series A.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in